11,000
Participants
Start Date
March 24, 2020
Primary Completion Date
December 30, 2023
Study Completion Date
August 31, 2025
No intervention
No intervention
Brigham and Women's Hospital, Boston
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of Colorado, Denver
OTHER
Anne Arundel Medical Center
INDIV
Beth Israel Deaconess Medical Center
OTHER
Jefferson Medical College of Thomas Jefferson University
OTHER
University of Virginia
OTHER
Brigham and Women's Hospital
OTHER